hellotayssir/FinQA_TAT-QA_financial_finetuning_dataset huggingface dataset:
note 4 : property , plant and equipment the following table summarizes the major classes of property , plant and equipment by category as of december 31 : 2015 2014 range of remaining useful weighted average useful life utility plant : land and other non-depreciable assets . . . . . . . . . . $ 141 $ 137 sources of supply . . . . . . . . . . . . . . . . . . . . . . . . . . 705 681 12 to 127 years 51 years treatment and pumping facilities . . . . . . . . . . . . . . 3070 2969 3 to 101 years 39 years transmission and distribution facilities . . . . . . . . . 8516 7963 9 to 156 years 83 years services , meters and fire hydrants . . . . . . . . . . . . . 3250 3062 8 to 93 years 35 years general structures and equipment . . . . . . . . . . . . . 1227 1096 1 to 154 years 39 years waste treatment , pumping and disposal . . . . . . . . . 313 281 2 to 115 years 46 years waste collection . . . . . . . . . . . . . . . . . . . . . . . . . . . 473 399 5 to 109 years 56 years construction work in progress . . . . . . . . . . . . . . . . 404 303 total utility plant . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18099 16891 nonutility property . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 405 378 3 to 50 years 6 years total property , plant and equipment . . . . . . . . . . . . . . . $ 18504 $ 17269 property , plant and equipment depreciation expense amounted to $ 405 , $ 392 , and $ 374 for the years ended december 31 , 2015 , 2014 and 2013 , respectively and was included in depreciation and amortization expense in the accompanying consolidated statements of operations . the provision for depreciation expressed as a percentage of the aggregate average depreciable asset balances was 3.13% ( 3.13 % ) for the year ended december 31 , 2015 and 3.20% ( 3.20 % ) for years december 31 , 2014 and 2013 . note 5 : allowance for uncollectible accounts the following table summarizes the changes in the company 2019s allowances for uncollectible accounts for the years ended december 31: .

Table:
 | 2015 | 2014 | 2013
balance as of january 1 | $ -35 ( 35 ) | $ -34 ( 34 ) | $ -27 ( 27 )
amounts charged to expense | -32 ( 32 ) | -37 ( 37 ) | -27 ( 27 )
amounts written off | 38 | 43 | 24
recoveries of amounts written off | -10 ( 10 ) | -7 ( 7 ) | -4 ( 4 )
balance as of december 31 | $ -39 ( 39 ) | $ -35 ( 35 ) | $ -34 ( 34 )
.

Question: what was the change in accumulated depreciation from depreciation expenses from 2013 to december 31 , 2015
Answer: 1171
Calculation: add(405, 392), add(#0, 374)
Operating assets and liabilities
5 Trade and other receivables
(a) Trade receivables
(i) Classification as trade receivables
Trade receivables are amounts due from customers for goods sold or services performed in the ordinary course of business. They are generally due for settlement within 30 - 60 days and therefore are all classified as current. Trade receivables are recognised initially at the amount of consideration that is unconditional unless they contain significant financing components, when they are recognised at fair value. The Group holds the trade receivables with the objective to collect the contractual cash flows and therefore measures them subsequently at amortised cost using the effective interest method.
(ii) Fair values of trade and other receivables
Due to the short-term nature of the trade and other receivables, their carrying amount is considered to be the same as their fair value.
(iii) Impairment and risk exposure
Information about the Group's impairment policies, calculation of loss allowance and exposure to credit risk, foreign currency risk and interest rate risk can be found in note 15.
(b) Interest receivable
Interest receivable relates to interest accrued on term deposits. Credit risk of this is assessed in the same manner as cash and cash equivalents which is detailed in note 15.
Table:
 |  | 30 June 2019 | 30 June 2018
 | Note | $'000 | $'000
Trade receivables | 5(a) | 28,320 | 36,522
Loss allowance (see note 15(b)) |  | (741) | (1,254)
 |  | 27,579 | 35,268
Interest receivable | 5(b) | 54 | 27
GST receivable |  | 6,222 | 162
Other receivables |  | 1 | 1,629
Total |  | 33,856 | 37,086


Question: What was the GST receivable for 2019 and 2018 respectively?
Answer: 6,222, 162
Restricted Share Units
The following table illustrates the number and WASP on date of award, and movements in, restricted share units (“RSUs”) and cash-based awards granted under the 2015 LTIP:
RSUs and cash-based awards have a vesting period between two to five years, with no award vesting within the first 12 months of the grant.
Table:
 | Year-ended 31 March 2019 |  | Year-ended 31 March 2018 | 
 | Number | WASP | Number | WASP
Restricted share units | 000’s | £ pence | 000’s | £ pence
Outstanding at the start of the year | 14,840 | 316.09 | 15,350 | 215.92
Awarded | 8,749 | 478.44 | 6,337 | 453.14
Forfeited | (1,421) | 426.11 | (1,421) | 284.15
Released | (6,822) | 309.77 | (5,426) | 218.49
Outstanding at the end of the year | 15,346 | 401.27 | 14,840 | 316.09


Question: What was the number of RSUs and cash-based awards outstanding at the end of the year in 2019?
Answer: 15,346
25. Loans and other borrowings continued
Net Debt
Net debt consists of loans and other borrowings (both current and non-current), less current asset investments and cash and cash equivalents. Loans and other borrowings are measured at the net proceeds raised, adjusted to amortise any discount over the term of the debt. For the purpose of this measure, current asset investments and cash and cash equivalents are measured at the lower of cost and net realisable value. Currency denominated balances within net debt are translated to sterling at swapped rates where hedged.
Net debt is considered to be an alternative performance measure as it is not defined in IFRS. The most directly comparable IFRS measure is the aggregate of loans and other borrowings (current and non-current), current asset investments and cash and cash equivalents. A reconciliation from the most directly comparable IFRS measure to net debt is given below.
A reconciliation from the most directly comparable IFRS measure to net debt is given below.
Table:
At 31 March | 2019 £m | 2018 £m | 2017 £m
Loans and other borrowings | 16,876 | 14,275 | 12,713
Less: |  |  | 
Cash and cash equivalents | (1,666) | (528) | (528)
Current asset investments | (3,214) | (3,022) | (1,520)
 | 11,996 | 10,725 | 10,665
Adjustments: |  |  | 
To retranslate debt balances at swap rates where hedged by currency swaps | (701) | (874) | (1,419)
To remove accrued interest applied to reflect the effective interest method and fair value adjustments | (260) | (224) | (314)
Net debt | 11,035 | 9,627 | 8,932


Question: For what years are information about  Loans and other borrowings provided?
Answer: 2019, 2018, 2017
The fair value of the option component of the ESPP shares was estimated at the grant date using the Black-Scholes option pricing model with the following weighted
average assumptions:
The Company issued 266 shares, 231 shares and 183 shares under the ESPP in the years ended December 31, 2019, 2018 and 2017, respectively, at a weighted average
exercise price per share of $86.51, $77.02, and $73.02, respectively. As of December 31, 2019, the Company expects to recognize $3,531 of the total unamortized compensation cost
related to employee purchases under the ESPP over a weighted average period of 0.37 years.
Table:
 |  | Year ended December 31 | 
 | 2019 | 2018 | 2017
Expected life (in years) | 0.5 | 0.5 | 0.5
Volatility | 36% - 37% | 33% - 40% | 29% - 37%
Risk-free interest rate | 1.58 - 2.43% | 1.76% - 2.50% | 0.76% - 1.16%
Dividend yield | - % | - % | - %


Question: What is the expected life (in years) of the option component of the ESPP shares in each of the years ended December 31, 2019?
Answer: 0.5, 0.5, 0.5
9. Income Taxes
On December 22, 2017, the Tax Act was enacted into law, which made changes to U.S. tax law, including, but not limited to: (1) reducing the U.S. Federal corporate income tax rate from 35% to 21%; (2) requiring companies to pay a one-time transition tax on certain unrepatriated earnings of foreign subsidiaries; (3) generally eliminating U.S. Federal corporate income taxes on dividends from foreign subsidiaries; (4) capitalizing R&D expenses which are amortized over five to 15 years; and (5) other changes to how foreign and domestic earnings are taxed.
The Tax Act includes a provision to tax global intangible low-taxed income (“GILTI”) of foreign subsidiaries and a base erosion anti-abuse tax (“BEAT”) measure that taxes certain payments between a U.S. corporation and its foreign subsidiaries. These provisions of the Tax Act were effective for the Company beginning August 1, 2018 and had no impact on the tax benefit for the year ended July 31, 2019.
Under U.S. GAAP, the Company can make an accounting policy election to either treat taxes due on the GILTI inclusion as a current period expense or factor such amounts into its measurement of deferred taxes. The Company has elected the current period expense method. The Company has finalized its assessment of the transitional impacts of the Tax Act.
In December 2018, the IRS issued proposed regulations related to the BEAT tax, which the Company is in the process of evaluating. If the proposed BEAT regulations are finalized in their current form, the impact may be material to the tax provision in the quarter of enactment.
The U.S. Treasury Department, the Internal Revenue Service (“IRS”), and other standard-setting bodies will continue to interpret or issue guidance on how provisions of the Tax Act will be applied or otherwise administered. The Company continues to obtain, analyze, and interpret guidance as it is issued and will revise its estimates as additional information becomes available.
Any legislative changes, including any other new or proposed U.S. Department of the Treasury regulations that have yet to be issued, may result in income tax adjustments, which could be material to our provision for income taxes and effective tax rate in the period any such changes are enacted. The Company’s income (loss) before provision for (benefit from) income taxes for the years ended July 31, 2019, 2018 and 2017 is as follows (in thousands):
Table:
 |  | Fiscal years ended July 31, | 
 | 2019 | 2018 | 2017
Domestic | $(1,778) | $(13,501) | $21,723
International | 14,230 | 5,225 | 6,803
Income (loss) before provision for (benefit from) income taxes | $12,452 | $(8,276) | $28,526


Question: What is the change in Income (loss) before provision for (benefit from) income taxes between 2017 and 2019?
Answer: -16074
Calculation: 12,452 - 28,526
Foreign Currency Translation Impact on Consolidated Financial Results
Since we are a U.S. domiciled company, we translate our foreign currency-denominated financial results into US Dollars. Due to the changes in the value of foreign currencies relative to the US Dollar, translating our financial results from foreign currencies to US Dollars may result in a favorable or unfavorable impact. Historically, the most significant currencies that have impacted the translation of our consolidated financial results are the euro, the Australian dollar, the Mexican peso, the British pound, the Canadian dollar, the Brazilian real and the Chinese Renminbi.
The following table presents the approximate favorable or (unfavorable) impact foreign currency translation had on certain of our consolidated financial results
Table:
(In millions) | 2019 vs. 2018 | 2018 vs. 2017
Net sales | $ (137.2) | $ (43.4)
Cost of sales | 98.4 | 31.7
Selling, general and administrative expenses | 16.3 | 1.0
Net earnings | (15.7) | (8.2)
Non-U.S. GAAP Adjusted EBITDA | (25.3) | (11.1)


Question: Historically, what currencies have impacted  the translation of their consolidated financial results most significantly?
Answer: euro, the Australian dollar, the Mexican peso, the British pound, the Canadian dollar, the Brazilian real and the Chinese Renminbi.
Stock-based compensation expense categorized by various equity components for the years ended December 31, 2019, 2018 and 2017 is summarized in the table below (in thousands):
During the years ended December 31, 2019, 2018 and 2017, the Company granted stock options covering zero, zero and 70,000 shares, respectively. The 2017 estimated per share fair value of the grant was $4.62 before estimated forfeitures.
The total fair value of restricted stock awards and units vested during the years ended December 31, 2019, 2018 and 2017 was $30.1 million, $30.4 million and $22.7 million, respectively.
The total intrinsic value of options exercised during the years ended December 31, 2019, 2018 and 2017 was $0.2 million, $1.0 million and $5.5 million, respectively. The intrinsic value is calculated as the difference between the market value on the date of exercise and the exercise price of the shares.
As of December 31, 2019, the unrecognized stock-based compensation balance after estimated forfeitures consisted of $0.1 million related to unvested stock options, to be recognized over an estimated weighted average amortization period of 1.5 years, and $40.3 million related to restricted stock awards and units, including performance-based awards and units, to be recognized over an estimated weighted average amortization period of 2.3 years.
As of December 31, 2018, the unrecognized stock-based compensation balance after estimated forfeitures related to unvested stock options was $0.3 million to be recognized over an estimated weighted average amortization period of 2.0 years and $40.6 million related to restricted stock awards and units, including performance-based awards and units, to be recognized over an estimated weighted average amortization period of 2.2 years.
Table:
 |  | Years Ended December 31, | 
 | 2019 | 2018 | 2017
Employee stock options | $219 | $438 | $1,980
Restricted stock awards and units | 29,031 | 27,974 | 28,909
Employee stock purchase plan | 2,304 | 2,599 | 2,573
Total stock-based compensation expense | $31,554 | $31,011 | $33,462


Question: What is the total fair value of restricted stock awards and units in 2018 and 2017, respectively? 
Answer: $30.4 million, $22.7 million
Postretirement Benefit Plans
The Company also provides certain postretirement health care and life insurance benefits to qualifying domestic retirees and their eligible dependents. The health care plan for shore-based employees and their dependents and seagoing licensed deck officers (“Deck Officers”) and their dependents is contributory at retirement, while the life insurance plan for all employees is noncontributory.
In general, postretirement medical coverage is provided to shore-based employees hired prior to January 1, 2005 and all Deck Officers who retire and have met minimum age and service requirements under a formula related to total years of service. The Company no longer provides prescription drug coverage to its retirees or their beneficiaries once they reach age 65.
The Company does not currently fund these benefit arrangements and has the right to amend or terminate the health care and life insurance benefits at any time.
Information with respect to the domestic pension and postretirement benefit plans for which the Company uses a December 31 measurement date, follow:
Table:
 | 2019 | 2018 | 2019 | 2018
At December 31, |  |  | Change in benefit obligation: | Change in benefit obligation:
Benefit obligation at beginning of year | $44,015 | $48,500 | $3,401 | $4,548
Cost of benefits earned (service cost) | — | — | 105 | 119
Interest cost on benefit obligation | 1,802 | 1,673 | 140 | 142
Actuarial losses/(gains) | 3,805 | (3,456) | 84 | (1,206)
Benefits paid | (2,686) | (2,702) | (158) | (202)
Benefit obligation at year end | 46,936 | 44,015 | 3,572 | 3,401
Change in plan assets: |  |  |  | 
Fair value of plan assets at beginning of year | 31,929 | 35,591 | — | —
Actual return on plan assets | 6,790 | (1,882) | — | —
Employer contributions | 721 | 922 | 158 | 202
Benefits paid | (2,686) | (2,702) | (158) | (202)
Fair value of plan assets at year end | 36,754 | 31,929 | — | —
Unfunded status at December 31 | $(10,182) | $(12,086) | $(3,572) | $(3,401)


Question: What was the Interest cost on benefit obligation in 2019 and 2018 respectively?
Answer: 1,802, 1,673
table of contents company stock performance the following graph shows a five-year comparison of cumulative total shareholder return , calculated on a dividend reinvested basis , for the company , the s&p 500 composite index ( the 201cs&p 500 201d ) and the s&p computers ( hardware ) index ( the 201cindustry index 201d ) . the graph assumes $ 100 was invested in each of the company 2019s common stock , the s&p 500 , and the industry index on september 30 , 2003 . data points on the graph are annual . note that historic stock price performance is not necessarily indicative of future stock price performance . copyright a9 2008 , standard & poor 2019s , a division of the mcgraw-hill companies , inc . all rights reserved. .

Table:
 | sep-03 | sep-04 | sep-05 | sep-06 | sep-07 | sep-08
apple inc . | $ 100 | $ 187 | $ 517 | $ 743 | $ 1481 | $ 1097
s&p a9500 | $ 100 | $ 114 | $ 128 | $ 142 | $ 165 | $ 129
s&p a9computer hardware | $ 100 | $ 104 | $ 119 | $ 128 | $ 188 | $ 158
s&p a9 500 $ 100 $ 114 $ 128 $ 142 $ 165 $ 129 s&p a9 computer hardware $ 100 $ 104 $ 119 $ 128 $ 188 $ 158 .

Question: what was the change in cumulative total return for the s&p a9500 between 2003 and 2004?
Answer: 14
Calculation: subtract(const_100, 114)
Notes to Consolidated Financial Statements - (Continued) Fiscal Years Ended May 26, 2019, May 27, 2018, and May 28, 2017 (columnar dollars in millions except per share amounts) General
The Revolving Credit Facility (as defined in Note 5) and the Term Loan Agreement generally require our ratio of earnings before interest, taxes, depreciation and amortization ("EBITDA") to interest expense not to be less than 3.0 to 1.0 and our ratio of funded debt to EBITDA not to exceed certain decreasing specified levels, ranging from 5.875 through the first quarter of fiscal 2020 to 3.75 from the second quarter of fiscal 2023 and thereafter, with each ratio to be calculated on a rolling fourquarter basis. As of May 26, 2019, we were in compliance with all financial covenants under the Revolving Credit Facility and the Term Loan Agreement.
Net interest expense consists of:
Interest paid from continuing operations was $375.6 million, $164.5 million, and $223.7 million in fiscal 2019, 2018, and 2017, respectively.
Table:
 | 2019 | 2018 | 2017
Long-term debt | $385.9 | $161.2 | $203.6
Short-term debt | 15.0 | 4.8 | 0.6
Interest income | (6.8) | (3.8) | (3.7)
Interest capitalized | (2.7) | (3.5) | (5.0)
 | $391.4 | $158.7 | $195.5


Question: What is the required ratio of earnings before interest, taxes, depreciation, and amortization ("EBITDA") to interest expense by The Revolving Credit Facility and the Term Loan Agreement?
Answer: not to be less than 3.0 to 1.0
The following table includes additional fair value information on financial assets and liabilities as at December 31, 2019 and 2018:
(1) Cash equivalents primarily correspond to deposits at call with banks.
(2) The carrying amount of the senior unsecured convertible bonds as reported above corresponds to the liability component only. For the convertible bonds issued on July 3, 2017 and outstanding as at December 31, 2017, the carrying amount of the senior unsecured convertible bonds corresponds to the liability component only, since, at initial recognition, an amount of $242 million was recorded directly in shareholders’ equity as the value of the equity instrument embedded in the convertible instrument.
Table:
 | 2019 | 2019 | 2019 | 2018 | 2018
 | Level | Carrying Amount | Estimated Fair Value | Carrying Amount | Estimated Fair Value
Cash equivalents (1) | 1 | 1,691 | 1,691 | 2,138 | 2,138
Long-term debt |  |  |  |  | 
– Bank loans (including current portion) | 2 | 718 | 718 | 594 | 594
– Senior unsecured convertible bonds (2) | 1 | 1,354 | 2,103 | 1,316 | 1,501


Question: How much amount was recorded in shareholders’ equity as the value of the equity instrument embedded in the convertible instrument?
Answer: $242 million
3 Segmental reporting continued
Capital additions, depreciation, amortisation and impairment
Capital additions include property, plant and equipment of £59.0m (2018: £33.5m), of which £8.1m (2018: £0.2m) was from acquisitions in the period, and other intangible assets of £72.0m (2018: £19.0m) of which £60.2m (2018: £9.1m) relates to acquired intangibles from acquisitions in the period. Right-of-use asset additions of £48.9m occurred during the 12 month period to 31st December 2019, of which £36.1m relates to additions on 1st January 2019 as a result of transition to IFRS 16, £11.7m relates to new leases entered into in 2019 and £1.1m from acquisitions. Capital additions split between the UK and rest of the world are UK £36.8m (2018: £20.1m) and rest of the world £143.1m (2018: £32.4m).
Table:
 | 2019 | 2019 | 2018 | 2018
 | Capital additions | Depreciation, amortisation and impairment | Capital additions | Depreciation and amortisation
 | £m | £m | £m | £m
Steam Specialties | 57.7 | 35.8 | 27.9 | 30.1
Electric Thermal Solutions | 81.6 | 18.4 | 6.0 | 13.6
Watson-Marlow | 40.6 | 22.4 | 18.6 | 14.4
Group total | 179.9 | 76.6 | 52.5 | 58.1


Question: What does capital additions include?
Answer: property, plant and equipment of £59.0m (2018: £33.5m), of which £8.1m (2018: £0.2m) was from acquisitions in the period, and other intangible assets of £72.0m (2018: £19.0m) of which £60.2m (2018: £9.1m) relates to acquired intangibles from acquisitions in the period
Changes in Estimates on Contracts
Changes in estimates related to contracts accounted for using the cost-to-cost method of accounting are recognized in the period in which such changes are made for the inception-to-date effect of the changes, with the exception of contracts acquired through a business combination, where the adjustment is made for the period commencing from the date of acquisition.
Changes in estimates on contracts for the periods presented were as follows:
The impact on diluted EPS attributable to Leidos common stockholders is calculated using the Company's statutory tax rate.
Table:
 |  | Year Ended | 
 | January 3, 2020 | December 28, 2018 | December 29, 2017
 |  | (in millions, except for per share amounts) | 
Favorable impact | $95 | $167 | $185
Unfavorable impact | (52) | (62) | (82)
Net favorable impact to income before income taxes | $43 | $105 | $103
Impact on diluted EPS attributable to Leidos common stockholders | $0.23 | $0.52 | $0.41


Question: In which period was Favorable impact more than 100 million?
Answer: 2018, 2017
Calculation: locate and analyze Favorable impact in row 5